Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) Global Forecast to 2023
[340 Pages Report] The immunoassay-based point-of-care (POC) testing and rapid testing industries have witnessed significant growth over the last few years owing to the increasing adoption of POC testing products in home care as well as in hospitals. Factors such as the rising prevalence of chronic and infectious diseases, technological advancements in POC testing products, and growing patient awareness of POC testing are some of the major factors driving the demand for immunoassay based POC testing and rapid testing across the globe. The global immunoassays market is expected to reach $27.15 billion by 2023 from $20.19 billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments.
By product and service, the reagents and kits segment commanded the largest share of the market in 2017
On the basis product and service, this market is classified into reagents and kits, analyzers, and software and services. In 2017, the reagents and kits segment accounted for the largest share of the immunoassays market. The large share of this segment can primarily be attributed to the requirement of the repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.
The chemiluminescence immunoassays (CLIAs) segment led the immunoassays market in 2017
By platform, this market is classified into CLIAs, radioimmunoassay (RIAs), colorimetric immunoassays (CIs), fluorescence immunoassays (FIAs), and other platforms. The CLIAs segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based tests.
By technology, the enzyme-linked immunosorbent assays (ELISA) segment accounted for the largest share of the market in 2017
On the basis of technology, the immunoassays market is segmented into ELISA, rapid tests, western blotting, enzyme-linked immunospot (ELISPOT), immuno-PCR, and other immunoassay technologies. The ELISA segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the increasing use of immunoassay tests in cancer, infectious diseases, and therapeutic drug level monitoring.
North America held the largest share of the market in 2017
Based on region, the immunoassay market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2017. The large share of this regional segment is attributed to the increasing incidence of chronic diseases and improved healthcare infrastructure.
Market Dynamics
Restraint: Unfavourable reimbursement scenario
Inadequate reimbursement is a major factor restraining the growth of the immunoassay market. In the US, Medicare revised its reimbursement mechanism for some IVD tests, including immunoassays and molecular tests, in 2012. Some of these molecular pathology tests do not have their own Healthcare Common Procedure Coding System (HCPCS) codes and are instead billed using unlisted codes. In such cases, Medicare Administrative Contractors (MACs) establish a payment amount for their local jurisdictions. According to the CMS, ~75% of tests showed reductions in reimbursement rates from January 2017. Some of these tests include molecular tests, targeted NGS analysis panels of five to 50 genes, and cancer tests. These developments are expected to adversely affect the US molecular and genetic testing market, which, in turn, will restrain the growth of the immunoassay market.
Opportunity: Increasing importance of companion diagnostics in the immunoassay market
Companion diagnostics include tests or assays intended to assist healthcare providers in making treatment decisions for patients based on the best response to therapy. The co-development of companion diagnostics with therapeutic products has the potential to significantly alter the drug development process and commercialize drug candidates by yielding safer drugs with enhanced therapeutic efficacy quickly and cost-effectively. With an increase in the demand for high-priced specialist therapies and safer drugs, the market for companion diagnostics is expected to showcase a high growth potential.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20152023 |
|
Base year considered |
2016 |
|
Forecast period |
20172023 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product and Services, Technology, Platform, Specimen, Application, End Users and Region |
|
Geographies covered |
North America (US, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and RoE), Asia (Japan, China, South Korea, India, Australia, Indonesia and RoAPAC), Latin America and Middle East and Africa. |
|
Companies covered |
Major ten players covered, including |
This report categorizes the immunoassays market into the following segments:
By Product & Service
- Reagents & Kits
- Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
- Rapid Test Reagents and Kits
- Enzyme-linked Immunospot ELISPOT Reagents and Kits
- Western Blot Reagents and Kits
- Other Reagents & Kits
- Analyzers
- By Type
- Open-ended Systems
- Closed-ended systems
- By Purchase Mode
- Rental Purchase
- Outright Purchase
- By Type
- Software & Services
By Platform
- Chemiluminescence Immunoassays (CLIAs)
- Fluorescence Immunoassays (FIAs)
- Colorimetric Immunoassays (CIs)
- Radioimmunoassays (RIAs)
- Other Platforms
By Technology
- ELISA
- First-generation
- Second-generation
- Third-generation
- Fourth-generation & Above
- Rapid Tests
- Western Blotting
- ELISPOT
- Immuno-PCR
- Other Technologies
By Specimen
- Blood
- Saliva
- Urine
- Other Specimens
By Application
- Infectious Diseases
- Endocrinology
- Oncology
- Bone & Mineral Disorders
- Cardiology
- Hematology & Blood Screening
- Autoimmune Disorders
- Toxicology
- Neonatal Screening
- Other Applications
By End User
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs)
- Blood Banks
- Research & Academic Laboratories
- Other End Users
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Indonesia
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Market Players
Roche, Abbott Laboratories, Siemens, Danaher Corporation, and DiaSorin
Recent Developments
Product Launches
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends for the Immunoassay market?
- Which segment provides the most opportunity for growth?
- Who are the leading vendors operating in this market?
- What are the opportunities for new market entrants?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 29)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 37)
4 PREMIUM INSIGHTS (Page No. - 43)
4.1 IMMUNOASSAYS: MARKET OVERVIEW
4.2 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY PLATFORM (2017)
4.3 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE (20182023)
4.4 GEOGRAPHICAL SNAPSHOT OF THE IMMUNOASSAYS MARKET
5 MARKET OVERVIEW (Page No. - 47)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of chronic and infectious diseases
5.2.1.1.1 Increasing use of Immunoassays in Oncology
5.2.1.1.2 Growing geriatric population
5.2.1.2 Technological advancements in immunoassay instruments and introduction of novel automated systems
5.2.1.3 Growth in the biotechnology and biopharmaceutical industries
5.2.1.4 Increasing adoption of immunoassay-based point-of-care testing and rapid testing
5.2.1.5 Vital role of immunoassays in drug and alcohol testing
5.2.1.5.1 Growing drug and alcohol consumption
5.2.1.5.2 Enforcement of stringent laws mandating drug and alcohol testing
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory requirements for the approval of immunoassay instruments and consumables
5.2.2.2 Implementation of excise duty on the sale of medical devices in the US
5.2.2.3 Unfavorable reimbursement scenario
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Increasing importance of companion diagnostics in the immunoassays market
5.2.3.3 Development of condition-specific biomarkers and tests
5.2.3.4 Integration of microfluidics technology in immunoassays
5.2.4 CHALLENGES
5.2.4.1 Complexities in conducting diagnostic tests
6 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE (Page No. - 61)
6.1 INTRODUCTION
6.2 REAGENTS & KITS
6.2.1 REAGENTS & KITS MARKET, BY TYPE
6.2.1.1 ELISA Reagents & kits
6.2.1.2 Rapid test reagents & kits
6.2.1.3 ELISPOT reagents & kits
6.2.1.4 Western blot reagents & kits
6.2.1.5 Other reagents & kits
6.3 ANALYZERS
6.3.1 IMMUNOASSAY ANALYZERS MARKET, BY TYPE
6.3.1.1 Open-ended systems
6.3.1.2 Closed-ended systems
6.3.2 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE
6.3.2.1 Rental purchase
6.3.2.2 Outright purchase
6.4 SOFTWARE & SERVICES
7 IMMUNOASSAYS MARKET, BY PLATFORM (Page No. - 78)
7.1 INTRODUCTION
7.2 CHEMILUMINESCENCE IMMUNOASSAYS
7.3 FLUORESCENCE IMMUNOASSAYS
7.4 COLORIMETRIC IMMUNOASSAYS
7.5 RADIOIMMUNOASSAYS
7.6 OTHER PLATFORMS
8 IMMUNOASSAYS MARKET, BY TECHNOLOGY (Page No. - 86)
8.1 INTRODUCTION
8.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
8.2.1 ELISA MARKET, BY GENERATION
8.2.1.1 First-generation ELISA
8.2.1.2 Second-generation ELISA
8.2.1.3 Third-generation ELISA
8.2.1.4 Fourth-generation & Above ELISA
8.3 RAPID TESTS
8.4 ENZYME-LINKED IMMUNOSPOT
8.5 WESTERN BLOTTING
8.6 IMMUNO-PCR
8.7 OTHER TECHNOLOGIES
9 IMMUNOASSAYS MARKET, BY SPECIMEN TYPE (Page No. - 102)
9.1 INTRODUCTION
9.2 BLOOD
9.3 SALIVA
9.4 URINE
9.5 OTHER SPECIMENS
10 IMMUNOASSAYS MARKET, BY APPLICATION (Page No. - 108)
10.1 INTRODUCTION
10.2 INFECTIOUS DISEASES
10.3 ENDOCRINOLOGY
10.4 ONCOLOGY
10.5 BONE & MINERAL DISORDERS
10.6 CARDIOLOGY
10.7 HEMATOLOGY & BLOOD SCREENING
10.8 AUTOIMMUNE DISORDERS
10.9 TOXICOLOGY
10.10 NEONATAL SCREENING
10.11 OTHER APPLICATIONS
11 IMMUNOASSAYS MARKET, BY END USER (Page No. - 123)
11.1 INTRODUCTION
11.2 HOSPITALS
11.3 CLINICAL LABORATORIES
11.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES & CROS
11.5 BLOOD BANKS
11.6 RESEARCH & ACADEMIC LABORATORIES
11.7 OTHER END USERS
12 GLOBAL IMMUNOASSAYS MARKET, BY REGION (Page No. - 133)
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 ITALY
12.3.3 FRANCE
12.3.4 SPAIN
12.3.5 UK
12.3.6 RUSSIA
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 JAPAN
12.4.2 CHINA
12.4.3 INDIA
12.4.4 AUSTRALIA
12.4.5 SOUTH KOREA
12.4.6 INDONESIA
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE (Page No. - 289)
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS
13.3 COMPETITIVE SITUATION AND TRENDS
13.3.1 PRODUCT LAUNCHES
13.3.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
13.3.3 EXPANSIONS
13.3.4 ACQUISITIONS
14 COMPANY PROFILES (Page No. - 294)
14.1 ROCHE
14.1.1 BUSINESS OVERVIEW
14.1.2 PRODUCTS OFFERED
14.1.3 RECENT DEVELOPMENTS
14.1.4 SWOT ANALYSIS
14.1.5 MNM VIEW
14.2 ABBOTT LABORATORIES
14.2.1 PRODUCTS OFFERED
14.2.2 RECENT DEVELOPMENTS
14.2.3 SWOT ANALYSIS
14.2.4 MNM VIEW
14.3 SIEMENS
14.3.1 PRODUCTS OFFERED
14.3.2 RECENT DEVELOPMENTS
14.3.3 SWOT ANALYSIS
14.3.4 MNM VIEW
14.4 DANAHER
14.4.1 PRODUCTS OFFERED
14.4.2 RECENT DEVELOPMENTS
14.4.3 SWOT ANALYSIS
14.4.4 MNM VIEW
14.5 DIASORIN
14.5.1 PRODUCTS OFFERED
14.5.2 RECENT DEVELOPMENTS
14.5.3 MNM VIEW
14.6 SYSMEX
14.6.1 PRODUCTS OFFERED
14.6.2 RECENT DEVELOPMENTS
14.6.3 MNM VIEW
14.7 BIOMΙRIEUX
14.7.1 PRODUCTS OFFERED
14.7.2 RECENT DEVELOPMENTS
14.7.3 MNM VIEW
14.8 ORTHO CLINICAL DIAGNOSTICS
14.8.1 PRODUCTS OFFERED
14.8.2 RECENT DEVELOPMENTS
14.8.3 MNM VIEW
14.9 QIAGEN
14.9.1 PRODUCTS OFFERED
14.9.2 RECENT DEVELOPMENTS
14.9.3 MNM VIEW
14.10 THERMO FISHER SCIENTIFIC
14.10.1 PRODUCTS OFFERED
14.10.2 RECENT DEVELOPMENTS
14.11 BECTON, DICKINSON & COMPANY
14.11.1 BUSINESS OVERVIEW
14.11.2 PRODUCTS OFFERED
14.11.3 RECENT DEVELOPMENTS
14.11.4 MNM VIEW
14.12 BIO-RAD LABORATORIES
14.12.1 BUSINESS OVERVIEW
14.12.2 PRODUCTS OFFERED
14.12.3 RECENT DEVELOPMENTS
14.12.4 MNM VIEW
14.13 AGILENT TECHNOLOGIES
14.13.1 BUSINESS OVERVIEW
14.13.2 PRODUCTS OFFERED
14.13.3 RECENT DEVELOPMENTS
14.13.4 MNM VIEW
14.14 MINDRAY
14.14.1 BUSINESS OVERVIEW
14.14.2 PRODUCTS OFFERED
14.14.3 RECENT DEVELOPMENTS
14.14.4 MNM VIEW
14.15 PERKINELMER
14.15.1 BUSINESS OVERVIEW
14.15.2 PRODUCTS OFFERED
14.15.3 RECENT DEVELOPMENTS
14.15.4 MNM VIEW
14.16 QUIDEL
14.16.1 BUSINESS OVERVIEW
14.16.2 PRODUCTS OFFERED
14.16.3 RECENT DEVELOPMENTS
14.17 MERCK
14.17.1 BUSINESS OVERVIEW
14.17.2 PRODUCTS OFFERED
14.17.3 RECENT DEVELOPMENTS
14.17.4 MNM VIEW
14.18 BIO-TECHNE
14.18.1 BUSINESS OVERVIEW
14.18.2 PRODUCTS OFFERED
14.18.3 RECENT DEVELOPMENTS
14.18.4 MNM VIEW
15 APPENDIX (Page No. - 353)
15.1 INDUSTRY INSIGHTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
15.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
15.5 AVAILABLE CUSTOMIZATIONS
15.6 RELATED REPORTS
15.7 AUTHOR DETAILS
LIST OF TABLES (293 TABLES)
TABLE 1 GLOBAL INCIDENCE OF INFECTIOUS DISEASES IN 2015
TABLE 2 GLOBAL INCIDENCE OF THE TOP 10 CANCERS (2012, 2015, & 2035)
TABLE 3 DETECTION OF DRUGS BY URINE TESTING
TABLE 4 NEW TESTS LAUNCHED BY KEY PLAYERS
TABLE 5 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 6 IMMUNOASSAY REAGENTS & KITS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 7 IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 8 ELISA REAGENTS & KITS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 9 RAPID TEST REAGENTS & KITS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 10 ELISPOT REAGENTS & KITS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 11 WESTERN BLOT REAGENTS & KITS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 12 OTHER REAGENTS & KITS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 13 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 14 IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 15 OPEN-ENDED SYSTEMS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 16 CLOSED-ENDED SYSTEMS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 17 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 18 IMMUNOASSAY ANALYZERS RENTAL PURCHASE MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 19 IMMUNOASSAY ANALYZERS OUTRIGHT PURCHASE MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 20 IMMUNOASSAY SOFTWARE & SERVICES MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 21 IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 22 CLIA SYSTEMS AVAILABLE IN THE MARKET
TABLE 23 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 24 FLUORESCENCE IMMUNOASSAYS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 25 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 26 RADIOIMMUNOASSAYS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 27 OTHER PLATFORMS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 28 IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 29 KEY ELISA SYSTEMS AVAILABLE IN THE MARKET
TABLE 30 ELISA MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 31 ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 32 FIRST-GENERATION ELISA MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 33 SECOND-GENERATION ELISA MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 34 THIRD-GENERATION ELISA MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 35 FOURTH-GENERATION & ABOVE ELISA MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 36 KEY RAPID TESTS AVAILABLE IN THE MARKET
TABLE 37 RAPID TESTS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 38 ELISPOT MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 39 WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET
TABLE 40 WESTERN BLOTTING MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 41 IMMUNO-PCR MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 42 OTHER IMMUNOASSAY TECHNOLOGIES MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 43 IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 44 IMMUNOASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 20162023 (USD MILLION)
TABLE 45 IMMUNOASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 20162023 (USD MILLION)
TABLE 46 IMMUNOASSAYS MARKET FOR URINE SAMPLES, BY REGION, 20162023 (USD MILLION)
TABLE 47 IMMUNOASSAYS MARKET FOR OTHER SPECIMENS, BY REGION, 20162023 (USD MILLION)
TABLE 48 IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 49 IMMUNOASSAYS MARKET FOR INFECTIOUS DISEASES, BY REGION, 20162023 (USD MILLION)
TABLE 50 IMMUNOASSAYS MARKET FOR ENDOCRINOLOGY, BY REGION, 20162023 (USD MILLION)
TABLE 51 IMMUNOASSAYS MARKET FOR ONCOLOGY, BY REGION, 20162023 (USD MILLION)
TABLE 52 IMMUNOASSAYS MARKET FOR BONE & MINERAL DISORDERS, BY REGION, 20162023 (USD MILLION)
TABLE 53 IMMUNOASSAYS MARKET FOR CARDIOLOGY, BY REGION, 20162023 (USD MILLION)
TABLE 54 IMMUNOASSAYS MARKET FOR HEMATOLOGY & BLOOD SCREENING, BY REGION, 20162023 (USD MILLION)
TABLE 55 IMMUNOASSAYS MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 20162023 (USD MILLION)
TABLE 56 IMMUNOASSAYS MARKET FOR TOXICOLOGY, BY REGION, 20162023 (USD MILLION)
TABLE 57 IMMUNOASSAYS MARKET FOR NEONATAL SCREENING, BY REGION, 20162023 (USD MILLION)
TABLE 58 IMMUNOASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 20162023 (USD MILLION)
TABLE 59 IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 60 IMMUNOASSAYS MARKET FOR HOSPITALS, BY REGION, 20162023 (USD MILLION)
TABLE 61 IMMUNOASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 20162023 (USD MILLION)
TABLE 62 IMMUNOASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 20162023 (USD MILLION)
TABLE 63 IMMUNOASSAYS MARKET FOR BLOOD BANKS, BY REGION, 20162023 (USD MILLION)
TABLE 64 IMMUNOASSAYS MARKET FOR RESEARCH & ACADEMIC LABORATORIES, BY REGION, 20162023 (USD MILLION)
TABLE 65 IMMUNOASSAYS MARKET FOR OTHER END USERS, BY REGION, 20162023 (USD MILLION)
TABLE 66 IMMUNOASSAYS MARKET, BY REGION, 20162023 (USD MILLION)
TABLE 67 NORTH AMERICA: IMMUNOASSAYS MARKET, BY COUNTRY, 20162023 (USD MILLION)
TABLE 68 NORTH AMERICA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 69 NORTH AMERICA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 70 NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 71 NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 72 NORTH AMERICA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 73 NORTH AMERICA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 74 NORTH AMERICA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 75 NORTH AMERICA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 76 NORTH AMERICA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 77 NORTH AMERICA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 78 US: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 79 US: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 80 US: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 81 US: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 82 US: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 83 US: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 84 US: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 85 US: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 86 US: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 87 US: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 88 CANADA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 89 CANADA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 90 CANADA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 91 CANADA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 92 CANADA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 93 CANADA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 94 CANADA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 95 CANADA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 96 CANADA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 97 CANADA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 98 MEXICO: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 99 MEXICO: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 100 MEXICO: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 101 MEXICO: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 102 MEXICO: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 103 MEXICO: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 104 MEXICO: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 105 MEXICO: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 106 MEXICO: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 107 MEXICO: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 108 EUROPE: IMMUNOASSAYS MARKET, BY COUNTRY, 20162023 (USD MILLION)
TABLE 109 EUROPE: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 110 EUROPE: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 111 EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 112 EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 113 EUROPE: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 114 EUROPE: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 115 EUROPE: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 116 EUROPE: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 117 EUROPE: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 118 EUROPE: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 119 GERMANY: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 120 GERMANY: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 121 GERMANY: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 122 GERMANY: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 123 GERMANY: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 124 GERMANY: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 125 GERMANY: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 126 GERMANY: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 127 GERMANY: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 128 GERMANY: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 129 ITALY: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 130 ITALY: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 131 ITALY: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 132 ITALY: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 133 ITALY: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 134 ITALY: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 135 ITALY: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 136 ITALY: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 137 ITALY: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 138 ITALY: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 139 FRANCE: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 140 FRANCE: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 141 FRANCE: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 142 FRANCE: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 143 FRANCE: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 144 FRANCE: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 145 FRANCE: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 146 FRANCE: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 147 FRANCE: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 148 FRANCE: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 149 SPAIN: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 150 SPAIN: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 151 SPAIN: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 152 SPAIN: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 153 SPAIN: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 154 SPAIN: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 155 SPAIN: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 156 SPAIN: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 157 SPAIN: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 158 SPAIN: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 159 UK: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 160 UK: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 161 UK: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 162 UK: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 163 UK: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 164 UK: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 165 UK: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 166 UK: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 167 UK: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 168 UK: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 169 RUSSIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 170 RUSSIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 171 RUSSIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 172 RUSSIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 173 RUSSIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 174 RUSSIA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 175 RUSSIA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 176 RUSSIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 177 RUSSIA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 178 RUSSIA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 179 ROE: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 180 ROE: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 181 ROE: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 182 ROE: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 183 ROE: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 184 ROE: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 185 ROE: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 186 ROE: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 187 ROE: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 188 ROE: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 189 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY COUNTRY, 20162023 (USD MILLION)
TABLE 190 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 191 ASIA PACIFIC: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 192 ASIA PACIFIC: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 193 ASIA PACIFIC: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 194 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 195 ASIA PACIFIC: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 196 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 197 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 198 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 199 ASIA PACIFIC: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 200 JAPAN: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 201 JAPAN: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 202 JAPAN: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 203 JAPAN: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 204 JAPAN: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 205 JAPAN: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 206 JAPAN: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 207 JAPAN: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 208 JAPAN: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 209 JAPAN: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 210 CHINA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 211 CHINA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 212 CHINA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 213 CHINA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 214 CHINA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 215 CHINA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 216 CHINA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 217 CHINA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 218 CHINA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 219 CHINA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 220 INDIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 221 INDIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 222 INDIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 223 INDIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 224 INDIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 225 INDIA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 226 INDIA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 227 INDIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 228 INDIA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 229 INDIA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 230 AUSTRALIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 231 AUSTRALIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 232 AUSTRALIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 233 AUSTRALIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 234 AUSTRALIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 235 AUSTRALIA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 236 AUSTRALIA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 237 AUSTRALIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 238 AUSTRALIA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 239 AUSTRALIA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 240 SOUTH KOREA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 241 SOUTH KOREA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 242 SOUTH KOREA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 243 SOUTH KOREA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 244 SOUTH KOREA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 245 SOUTH KOREA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 246 SOUTH KOREA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 247 SOUTH KOREA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 248 SOUTH KOREA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 249 SOUTH KOREA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 250 INDONESIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 251 INDONESIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 252 INDONESIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 253 INDONESIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 254 INDONESIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 255 INDONESIA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 256 INDONESIA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 257 INDONESIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 258 INDONESIA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 259 INDONESIA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 260 ROAPAC: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 261 ROAPAC: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 262 ROAPAC: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 263 ROAPAC: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 264 ROAPAC: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 265 ROAPAC: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 266 ROAPAC: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 267 ROAPAC: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 268 ROAPAC: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 269 ROAPAC: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 270 LATIN AMERICA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 271 LATIN AMERICA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 272 LATIN AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 273 LATIN AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 274 LATIN AMERICA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 275 LATIN AMERICA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 276 LATIN AMERICA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 277 LATIN AMERICA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 278 LATIN AMERICA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 279 LATIN AMERICA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 280 MEA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 20162023 (USD MILLION)
TABLE 281 MEA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 282 MEA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 20162023 (USD MILLION)
TABLE 283 MEA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 20162023 (USD MILLION)
TABLE 284 MEA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 20162023 (USD MILLION)
TABLE 285 MEA: ELISA MARKET, BY GENERATION, 20162023 (USD MILLION)
TABLE 286 MEA: IMMUNOASSAYS MARKET, BY PLATFORM, 20162023 (USD MILLION)
TABLE 287 MEA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 20162023 (USD MILLION)
TABLE 288 MEA: IMMUNOASSAYS MARKET, BY APPLICATION, 20162023 (USD MILLION)
TABLE 289 MEA: IMMUNOASSAYS MARKET, BY END USER, 20162023 (USD MILLION)
TABLE 290 PRODUCT LAUNCHES, 20142017
TABLE 291 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 20142017
TABLE 292 EXPANSIONS, 20142017
TABLE 293 ACQUISITIONS, 20142017
LIST OF FIGURES (50 FIGURES)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD BILLION)
FIGURE 7 IMMUNOASSAYS MARKET, BY PLATFORM, 2018 VS. 2023 (USD BILLION)
FIGURE 8 IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD BILLION)
FIGURE 9 IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2018 VS. 2023 (USD BILLION)
FIGURE 10 IMMUNOASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
FIGURE 11 IMMUNOASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
FIGURE 12 IMMUNOASSAYS MARKET, BY REGION, 2018 VS. 2023 (USD BILLION)
FIGURE 13 INCREASING INCIDENCE OF CHRONIC & INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS IN IMMUNOASSAY INSTRUMENTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 14 CHEMILUMINESCENCE IMMUNOASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC IMMUNOASSAYS MARKET IN 2017
FIGURE 15 SOFTWARE & SERVICES TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 16 CHINA & INDIA TO WITNESS THE HIGHEST GROWTH RATES IN THE IMMUNOASSAYS MARKET FROM 2018 TO 2023
FIGURE 17 IMMUNOASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 GLOBAL INCIDENCE OF DIABETES, BY REGION, 2017 VS. 2045
FIGURE 19 GLOBAL AGING POPULATION, BY REGION, 2017 VS. 2050 (MILLION)
FIGURE 20 IMMUNOASSAY REAGENTS & KITS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 21 ELISA REAGENTS & KITS SEGMENT TO DOMINATE THE IMMUNOASSAY REAGENTS & KITS MARKET DURING THE FORECAST PERIOD
FIGURE 22 OPEN-ENDED SYSTEMS SEGMENT TO DOMINATE THE IMMUNOASSAY ANALYZERS MARKET, BY TYPE, DURING THE FORECAST PERIOD
FIGURE 23 RENTAL PURCHASE SEGMENT TO DOMINATE THE IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, DURING THE FORECAST PERIOD
FIGURE 24 CHEMILUMINESCENCE IMMUNOASSAYS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 25 ELISA SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 26 FOURTH-GENERATION & ABOVE ELISA SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 27 BLOOD SAMPLES SEGMENT TO DOMINATE THE IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, DURING THE FORECAST PERIOD
FIGURE 28 INFECTIOUS DISEASES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 29 NUMBER OF PEOPLE LIVING WITH HIV GLOBALLY, 2010 - 2016
FIGURE 30 HOSPITALS SEGMENT TO DOMINATE THE IMMUNOASSAYS MARKET IN 2023
FIGURE 31 NORTH AMERICA TO DOMINATE THE GLOBAL IMMUNOASSAYS MARKET IN 2018
FIGURE 32 NORTH AMERICA: IMMUNOASSAYS MARKET SNAPSHOT
FIGURE 33 ASIA PACIFIC: IMMUNOASSAYS MARKET SNAPSHOT
FIGURE 34 MARKET SHARE ANALYSIS 2017
FIGURE 35 ROCHE: COMPANY SNAPSHOT (2017)
FIGURE 36 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
FIGURE 37 SIEMENS: COMPANY SNAPSHOT (2017)
FIGURE 38 DANAHER: COMPANY SNAPSHOT (2017)
FIGURE 39 DIASORIN: COMPANY SNAPSHOT (2016)
FIGURE 40 SYSMEX: COMPANY SNAPSHOT (2017)
FIGURE 41 BIOMΙRIEUX: COMPANY SNAPSHOT (2016)
FIGURE 42 QIAGEN: COMPANY SNAPSHOT (2016)
FIGURE 43 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
FIGURE 44 BD: COMPANY SNAPSHOT (2017)
FIGURE 45 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016)
FIGURE 46 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017)
FIGURE 47 PERKINELMER: COMPANY SNAPSHOT (2017)
FIGURE 48 QUIDEL: COMPANY SNAPSHOT (2016)
FIGURE 49 MERCK: COMPANY SNAPSHOT (2016)
FIGURE 50 BIO-TECHNE: COMPANY SNAPSHOT (2017)
Get in-depth analysis of the COVID-19 impact on the Immunoassay Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Immunoassay Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Immunoassay Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Immunoassay Market